System zur Verwaltung von Restladung für Mehrpunkt-Schrittmachertherapie
Anmelder: PACESETTER, INC. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP3479871
- Aktenzeichen
- EP18204012
- Anmeldetag
- 2. November 2018
- Veröffentlichung
- 3. März 2021
- Erteilung
- 3. März 2021
- Rechtsraum
- EP
- IPC
- A61N1/37A61N1/368
Abstract
A system (100) is provided for managing residual charge for multi-point pacing therapy. The system (100) provides an electrode configuration that includes an atrial (A) electrode (122, 123), a right ventricular (RV) electrode (132, 134) and multiple left ventricular (LV) electrodes (126 1-4 ). The system (100) delivers pacing pulses for an MPP therapy, during a first cardiac cycle, from a pulse generator (222) to the electrode configuration. The pacing pulses are separated by pacing pulse (PP) intervals. The system (100) dynamically adjusts at least one of a timing or a duration of discharge pulses for the residual charge to form a discharge sequence. The system (100) activates the discharge pulses based on the discharge sequence, during the first cardiac cycle, to the multiple LV electrodes (126 1-4 ) to distribute the residual charge across the PP intervals.
Anmelder
- Firma
- PACESETTER, INC.
- Land
- 🇺🇸 USA
US-amerikanisches Unternehmen der Medizintechnik, historisch Hersteller von Herzschrittmachern und implantierbaren Defibrillatoren, später Teil von Abbotts Herzrhythmus-Sparte.
364 Patente in unserer Datenbank
Fachgebiete
Vertreten von
-
Barker Brettell Sweden AB
Barker Brettell Sweden AB · Stockholm
-
Aros Patent AB
Aros Patent AB · Uppsala